# US 2004/0081580 A1 · Use of nitric oxide and a device in the therapeutic management of pathogens in mammals

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0081580 A1
- Document ID: US20040081580A1
- Status: Published application
- Kind: A1
- Application number: 10/658,665
- Filed: 2003-09-09
- Published: 2004-04-29
- Earliest claimed: 2002-09-10
- Inventors: Doug Hole; Christopher Miller
- Web page: https://patentgrep.com/patent/US20040081580A1

## CPC

- A61M 1/3687: {Chemical treatment (A61M1/3675 takes precedence)}
- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- A61M 1/1698: {Blood oxygenators with or without heat-exchangers (intracorporal A61M1/1678; manufacturing of membranes therefor B01D67/00; semi-permeable membranes for separation processes characterised by their properties B01D69/00; semi-permeable membranes characterised by their material B01D71/00)}
- A61M 2202/0275: Nitric oxide [NO]
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention relates to a method for the systemic delivery of the nitric oxide moiety either as a dissolved gas or through the administration of nitric oxide donors in an extracorporeal circuit to reduce whole body bacterial contamination by pathogenic or toxic substrates. The utilization of an extracorporeal circuit with the entrainment of nitric oxide is viewed as a novel modality in the medical management of bacteremia (blood poisoning) and/or septicemia in mammals.

## Claims

### Claim 1

A method of reducing pathogens in a mammal's blood stream by exposing the blood in an extracorporeal fluid with nitric oxide, comprising:
(a) providing an extracorporeal blood circuit comprising an inlet line adapted to receive blood from a patient or a blood source, an outlet line adapted to return blood to the patient and/or the blood source, a fluid circuit for fluid communication between the inlet and the outlet line, and at least one pump acting on the fluid circuit to circulate blood therethrough and out the outlet line,
(b) circulating the blood through the extracorporeal blood circuit, and
(c) exposing the blood in the circuit with nitric oxide gas in a concentration sufficient to reduce pathogenic content in the blood.

### Claim 2 (depends on 1)

The method of claim 1 further comprising including in the circuit a blood treatment component, treating blood with the component, and at least upstream of the component contacting blood in a portion of said circuit with nitric oxide gas in concentration sufficient to reduce pathogenic content in the blood.

### Claim 3 (depends on 2)

The method of claim 2 further comprising selecting said component from the group consisting of a dialysis component, an organ perfusion component, a heat exchange component, an oxygenation component, or a combination thereof.

### Claim 4

A method of reducing pathogens in blood in an extracorporeal fluid circuit of a cardiopulmonary bypass apparatus, comprising:
providing a cardiopulmonary bypass circuit that includes an inlet line adapted to receive blood from a patient or a blood source and an outlet line adapted to return blood to the patient and/or blood source, a reservoir connected to the inlet line for accumulation of blood received from the patient, an oxygenator, a fluid interconnection circuit for fluid communication between the reservoir and the oxygenator and between the oxygenator and the outlet line, and at least one pump acting on the fluid interconnection circuit to withdraw blood from the reservoir and circulate it through the oxygenator and out the outlet line, and
exposing the blood in a portion of the cardiopulmonary bypass circuit with nitric oxide gas in concentration sufficient to reduce pathogens in the blood.

### Claim 5 (depends on 4)

The method of claim 4 further comprising:
monitoring the rate of flow of blood through the cardiopulmonary bypass circuit,
introducing nitric oxide gas into the circuit, and
controlling the pressure and rate of flow of gas introduced into the circuit in relation to the flow of blood through the circuit to maintain the concentration of nitric oxide within a desired range sufficient to reduce pathogens of the blood.

### Claim 6 (depends on 4)

The method of claim 4 comprising introducing nitric oxide into a blood accumulator reservoir receiving blood from the patient for exposing with the blood.

### Claim 7 (depends on 4)

The method of claim 4 comprising
locating a semipermeable membrane selectively permeable to nitric oxide gas and impermeable to nitrogen gas in a portion of said fluid interconnection circuit distally proximate the reservoir in a longitudinal disposition adapted to allow contact of an outside of the membrane with blood flowing through the fluid interconnection circuit portion, and
delivering nitric oxide gas to the inside of the membrane under pressure sufficient to drive the nitric oxide across the membrane for contact with blood on the outside of the membrane within a desired concentration range sufficient to reduce pathogens in the blood.

### Claim 8 (depends on 7)

The method of claim 7 further comprising
providing the membrane in tubular form having an inlet and outlet and in coaxial disposition within the fluid interconnection circuit portion,
delivering the nitric oxide with a nitrogen carrier gas through the inlet and removing gas through the outlet sufficient to maintain the pressure and rate of flow, and
scavenging any nitric oxide present in the gas removed through the membrane outlet.

### Claim 9 (depends on 1)

The method of claim 1 wherein the pathogens are septicemia and/or bacteremia.

### Claim 10 (depends on 4)

The method of claim 4 wherein the pathogens are septicemia and/or bacteremia.

### Claim 11 (depends on 1)

The method of claim 1 wherein the nitric oxide gas is mixed with other gases.

### Claim 12 (depends on 4)

The method of claim 4 wherein the nitric oxide gas is mixed with other gases.

### Claim 13 (depends on 1)

The method of claim 1 further providing a free-radical scavenger unit that exposes the blood to free-radical scavengers after the blood is exposed to the nitric oxide.

### Claim 14 (depends on 4)

The method of claim 4 further providing a free-radical scavenger unit that exposes the blood to free-radical scavengers after the blood is exposed to the nitric oxide.

### Claim 15

An extracorporeal blood circuit comprising an inlet line adapted to receive blood from a patient or a blood source, an outlet line adapted to return blood to the patient and/or the blood source, a fluid circuit for fluid communication between the inlet and the outlet line, and at least one pump acting on the fluid circuit to circulate blood therethrough and out the outlet line,
a nitric oxide unit that exposes the blood in the circuit with nitric oxide gas in a concentration sufficient to reduce pathogenic content in the blood; and
a free radical scavenger unit that exposes the blood in the circuit and after being exposed to nitric oxide, with a free-radical scavenger in a concentration sufficient to reduce the nitric oxide content in the blood.

### Claim 16

A nitric oxide gas dispenser for mammals, comprising:
a component that provides nitric oxide gas and or aerosolized composition at a desired pressure and concentration, and a delivery system that provides the nitric oxide at the desired pressure to the mammal;
a valve mechanism that controls the flow of the nitric oxide so the mammal's lungs receive a predetermined amount of nitric oxide and the nitric oxide is of sufficient quantity that it is able to penetrate through the mammal's lungs to contact the mammal's blood cells to reduce the pathogens in the mammal's blood and not form excessive amounts of methemoglobin.

### Claim 17 (depends on 16)

The dispenser of claim 16 wherein the dispenser has a pressure sensor positioned along the delivery system and determines when the mammal is taking a breadth;
if the pressure sensor determines the mammal is taking a breadth, the pressure sensor transmits a breadth signal to a microprocessor, the microprocessor then determines if the mammal is within a prescribed time frame for the mammal to be administered nitric oxide;
if the microprocessor determines the mammal is within the prescribed time frame, the microprocessor transmits an open signal to the valve mechanism to release the predetermined amount of nitric oxide to the mammal to reduce pathogens in the blood system.

### Claim 18 (depends on 16)

The dispenser of claim 16 wherein the nitric oxide is transmitted into at least one nostril of the mammal, or the mouth of the mammal, or through a ventilator.

### Claim 19 (depends on 16)

The dispenser of claim 16 wherein the pathogens are septicemia and/or bacteremia.

### Claim 20 (depends on 16)

The dispenser of claim 16 wherein the nitric oxide is mixed with other gases.

### Claim 21

A method of reducing pathogens in a mammal's blood stream by exposing the blood that receives oxygen from the lungs with nitric oxide, comprising:
(a) administering nitric oxide from a nitric oxide dispenser unit to a mammal through a nasal canula, a mask or a ventilator circuit for a mammal breathing or on ventilator like support;
(b) exposing the blood in contact with the patient's lungs with nitric oxide in a concentration sufficient to reduce pathogenic content in the blood.

### Claim 22 (depends on 21)

The method of claim 21 wherein the pathogens are septicemia and/or bacteremia.

### Claim 23 (depends on 21)

The method of claim 21 wherein the nitric oxide is a gas.

### Claim 24 (depends on 21)

The method of claim 21 wherein the nitric oxide is delivered through an aerosolized donor compounds.

### Claim 25 (depends on 21)

The method of claim 21 wherein the nitric oxide is mixed with other gases.
